BioCentury
ARTICLE | Financial News

Nov. 1 Financial Quick Takes: Kira raises $13.8M series A; plus SinoMab, Tot, Shasqi and Sense Biodetection

November 1, 2019 11:33 PM UTC

Autoimmune play Kira launches with $13.8M series A
Kira Biotech raised A$20 million ($13.8 million) in a series A round led by OneVentures, IP Group and the Advance Queensland Business Development Fund. The Australian disease company will use the funds to advance its lead candidate KB312 through Phase I testing for an undisclosed autoimmune disease.

Pair of companies close in on Hong Kong IPOs
Two companies set terms for planned Hong Kong IPOs that could raise more than $280 million in total...